Number of viable CD34+cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation.

被引：0
|
作者：
Allan, DS
Keeney, M
Howson-Jan, K
Bhatia, M
Sutherland, DR
Chin-Yee, I
机构：
[1] Univ Western Ontario, London, ON, Canada
[2] Robarts Res Inst, London, ON N6A 5C1, Canada
[3] Toronto Hosp, Toronto, ON M5T 2S8, Canada
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1646
引用
收藏
页码：381A / 381A
页数：1
相关论文
共 50 条
  • [41] The role of CD34+cells, CFU and total nucleated cells in determining the target dose of stem cells prior to autologous stem cell transplantation
    Al Sabty, F.
    Demeckova, E.
    Hrubisko, M.
    Mistrik, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S133 - S134
  • [42] Risk of Engraftment Syndrome after Autologous Stem Cell Transplantation for Multiple Myeloma Increases with Age and Lower Dose of CD34+Cells, but Is Not Impacted By Immunomodulatory Chemotherapy
    McKiernan, Phyllis
    Siegel, David
    Rowley, Scott D.
    Vesole, David H.
    Andrews, Tracy
    Ortega, Andrea
    Skarbnik, Alan P.
    Biran, Noa
    Richter, Joshua R.
    Pecora, Andrew L.
    Goy, Andre
    Panchal, Rima M.
    Aleksidze, Nino
    Donato, Michele L.
    BLOOD, 2017, 130
  • [43] Absence of CD34-hematopoietic precursor population in the recipients of CD34+stem cell transplantation.
    Ando, K
    Kato, S
    Yabe, H
    Yabe, M
    Nakamura, Y
    Hotta, T
    BLOOD, 2000, 96 (11) : 113B - 113B
  • [44] Post-thaw viable CD34+ cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation
    Lee, S.
    Kim, S.
    Kim, H.
    Baek, E. J.
    Jin, H.
    Kim, J.
    Kim, H. O.
    VOX SANGUINIS, 2008, 94 (02) : 146 - 152
  • [45] Aldehyde dehydrogenase as an alternative to enumeration of total and viable CD34+ cells in autologous hematopoietic progenitor cell transplantation
    Veeraputhiran, Muthu
    Katragadda, Lakshmikanth
    Balamurugan, Appathurai
    Cottler-Fox, Michele
    CYTOTHERAPY, 2011, 13 (10) : 1256 - 1258
  • [46] Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation
    M M Sartor
    F Garvin
    V Antonenas
    K F Bradstock
    D J Gottlieb
    Bone Marrow Transplantation, 2007, 40 : 851 - 857
  • [47] Recovery of viable CD34+cells from cryopreserved haemopoietic stem cell products.
    Sartor, MM
    Garvin, F
    Antonenas, V
    Webb, M
    Bradstock, KF
    BLOOD, 2004, 104 (11) : 337B - 337B
  • [48] Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation
    Sartor, M. M.
    Garvin, F.
    Antonenas, V.
    Bradstock, K. F.
    Gottlieb, D. J.
    BONE MARROW TRANSPLANTATION, 2007, 40 (09) : 851 - 857
  • [49] POSITIVE SELECTION OF HEMATOPOIETIC CD-34 STEM-CELLS FOR AUTOLOGOUS TRANSPLANTATION
    LOPEZ, M
    BOCCACCIO, C
    DOUAY, L
    BONY, V
    LAPORTE, JP
    LESAGE, S
    ISNARD, F
    BOUCHET, S
    GIARRATANNA, MC
    ZAPPAVIGNA, S
    GOSSET, AC
    ROZENBAUM, H
    STAKOWIAK, J
    NAJMAN, A
    GRANDE, M
    GORIN, NC
    PRESSE MEDICALE, 1993, 22 (31): : 1439 - 1443
  • [50] Incidence and factors associated with the engraftment syndrome in autologous stem cell transplantation.
    Maiolino, A
    Nucci, M
    Lima, J
    Portugal, A
    Biasoli, I
    Pulcheri, W
    BLOOD, 2000, 96 (11) : 331B - 331B
12345